23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-60.59%
Negative revenue growth signals a shrinking top line, alarming for Benjamin Graham. Confirm if it’s cyclical or structural before proceeding.
-60.59%
Negative gross profit growth suggests either falling sales or rising direct costs. Benjamin Graham would consider this a fundamental warning sign.
-7.96%
Negative EBIT growth points to weakening core profitability. Benjamin Graham would question management efficiency.
-9.74%
Negative operating income growth means rising costs or falling revenues are eroding core profitability. Benjamin Graham would raise caution.
-12.96%
Negative net income growth shows profitability erosion. Benjamin Graham would worry about solvency and longer-term viability.
-13.79%
Negative EPS growth underscores deteriorating earnings per share. Benjamin Graham would worry about ongoing dilution or weakened profitability.
-13.79%
Negative diluted EPS growth suggests diluted shares grew or net income fell. Benjamin Graham would see this as a serious setback to shareholder value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.31%
Dividend growth 2-5% – Mild improvement. Peter Lynch would see if the company can accelerate dividend boosts as earnings grow.
-5.17%
Negative OCF growth is a critical warning sign. Benjamin Graham would check if receivables are ballooning or if core sales are declining.
-5.17%
Negative FCF growth reveals potential liquidity pressures or large capex overshadowing cash generation. Benjamin Graham would demand deeper scrutiny.
-63.23%
A negative 10Y CAGR in revenue/share implies a decade of top-line decline per share. Benjamin Graham would be extremely cautious about long-term viability.
-45.85%
Negative 5Y CAGR implies mid-term contraction. Benjamin Graham would be very cautious unless a turnaround story is evident.
-72.72%
Negative 3Y CAGR signals recent top-line contraction per share. Benjamin Graham would be skeptical unless a turnaround is clear.
193.94%
10Y OCF/share CAGR above 15% – Outstanding long-term cash-generation growth. Warren Buffett would check if reinvestment needs remain manageable.
25.98%
5Y OCF/share CAGR above 15% – Very robust mid-term cash expansion. Warren Buffett would check if reinvestment fosters sustainable growth.
5.80%
3Y OCF/share CAGR 5-10% – Decent. Seth Klarman would check if it’s consistent or just boosted by a single year.
140.71%
10Y net income/share CAGR above 15% – Exceptional long-term profit growth. Benjamin Graham would confirm if these gains hold through economic cycles.
57.92%
5Y net income/share CAGR above 15% – Strong mid-term profit growth. Benjamin Graham would check if leverage artificially boosts earnings.
-16.54%
Negative 3Y net income/share CAGR highlights recent bottom-line decay. Benjamin Graham would want clarity on cost vs. revenue drivers for the declines.
54.02%
10Y equity/share CAGR above 12% – Excellent long-term book value compounding. Warren Buffett would see if consistent profits plus moderate payouts drive this growth.
5.41%
5Y equity/share CAGR 5-8% – Solid. Seth Klarman checks if ROE remains healthy during these mid-term expansions.
-9.86%
Negative 3Y equity/share CAGR means a near-term drop in book value. Benjamin Graham would be cautious unless restructured operations promise a future rebound.
152.05%
10Y dividend/share CAGR above 15% – Remarkable long-term payout increases. Warren Buffett would confirm if these distributions are well-covered by free cash flow.
121.94%
Above 15% 5Y dividend/share CAGR – Impressive mid-term dividend increases. Warren Buffett would confirm if free cash flow comfortably supports them.
11.44%
3Y dividend/share CAGR above 10% – Strong short-term dividend expansion. Warren Buffett verifies coverage by operating cash flows.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.75%
Asset growth 0-5% – Minimal. Howard Marks notes the firm may be optimizing existing assets or being cautious with expansions.
2.56%
2-5% annual BV/share growth – Mild. Peter Lynch sees potential if expansions or margin lifts can accelerate compounding.
7.10%
Debt up 5-10% yoy – Noticeable leverage. Howard Marks questions if the returns outstrip higher interest costs.
No Data
No Data available this quarter, please select a different quarter.
10.30%
SG&A growth 10-15% – Potential overhead buildup. Howard Marks questions if margins shrink unless revenue scales accordingly.